Stock screener

IONS

Conviction 65HealthcareScan · Thu, Jun 25, 2026
IONS$78.35+2.38%
ResistanceSupportVol 14Insider sell
63 bars
2
2
3
2
Vol MA14 2.35M
Mar 26Apr 14May 1May 19Jun 8Jun 25
IONIS PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.ionis.com
Price78.35
Change+2.38%
Gap+0.58%
Rel volume4.46×
Avg volume2.11M
Avg $ vol158.95M
SMA 2074.82
SMA 5074.96
SMA 20075.32
Price vs 50+4.51%
Price vs 200+4.01%
MA stackmixed
50/200 crossdeath · 5d
Supertrendup · 71.09
RSI (14)64
MACD hist0.44
MACD crossbull · 3d
Stoch %K / %D84 / 74
ADX (14)14
+DI / −DI24 / 12
RSI divergence
MACD divergence
ATR %+2.86%
ADR %2.86%
52w high86.50
52w low39.51
From 52w high-9.43%
Above 52w low+98.29%
New 52w highNo
SqueezeOn · 45d
Bollinger width7.90%
%B1.10
Donchian pos84.90%
Donchian high79.47
Donchian low72.02
AVWAP (52w high)76.19
vs AVWAP high+2.83%
AVWAP (52w low)68.54
vs AVWAP low+14.31%
OBV trendUp
Chaikin MF (20)-0.06
Today vs 20d4.46×
Avg vol (14d)2.35M
Avg vol (20d)2.11M
Avg $ vol (20d)158.95M
Market cap12.95B
RS 3m (vs SPY)-2.44%
RS 6m (vs SPY)-11.57%
RS line new highNo
Trend template6/8
Technical rank57.5
1 week+5.43%
1 month+2.99%
3 months+7.76%
6 months-3.68%
1 year+97.64%
YTD-1.66%
P/E-33.95
P/B26.35
P/S13.72
P/FCF-40.46
EPS-2.38
Div yield
ROE-77.61%
ROA-11.05%
Debt/Eq3.58
Current4.10
EV/EBITDA
Gross margin
Net margin-40.41%
Rev growth33.83%
EPS growth15.97%
Price target104.61
Target upside33.52%
Analyst ratingBuy
Institutional116.90%
Ent. value14.53B
Revenue246.09M
Net income-92.53M
Gross profit
Free cash flow-320.03M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out165.26M
Employees1.4K
ListedFri, May 17, 1991
Free float157.03M
Float %95.1%
Short interest16.99M
Days to cover10.0d
Short volume66.6%
Squeeze score79 / 100
Next earningsWed, Jul 29, 2026 (34d)
EPS forecast−$1.06 · 8 est
Last EPS vs est−$0.56 vs −$0.89
Last surprise+37.1% beat
Setup gradeB
Conviction65 / 100
Pattern quality
Tech rank57.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance78.65
Support72.08
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IONS

All disclosures →
No recent disclosed trades by Congress in IONS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IONS · 4 buys · 5 sells

InsiderSideShares
BERTHELSEN SPENCER R
Director · Common Stock · 2026-06-15
Exercise8K
BERTHELSEN SPENCER R
Director · Non-Qualified Stock Option (right to buy) · 2026-06-15
Exercise8K
BERTHELSEN SPENCER R
Director · Common Stock · 2026-06-15
Sell8K
Reikes Peter N
Director · Non-Qualified Stock Option (right to buy) · 2026-06-04
Grant10.75K
HANTSON LUDWIG
Director · Non-Qualified Stock Option (right to buy) · 2026-06-04
Grant10.75K
BERTHELSEN SPENCER R
Director · Common Stock · 2026-06-01
Sell8K
BERTHELSEN SPENCER R
Director · Common Stock · 2026-06-01
Exercise8K
BERTHELSEN SPENCER R
Director · Common Stock · 2026-06-01
Other
BERTHELSEN SPENCER R
Director · Non-Qualified Stock Option (right to buy) · 2026-06-01
Exercise8K
Monia Brett P
Chief Executive Officer · Common Stock · 2026-05-14
Sell3.22K

SEC filings

EDGAR filings in IONS · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.